Updates and news related to prostate cancer:
How to Take Care of the Heart?
J. David Prologo, MD, FSIR, ABOM-D, an interventional radiologist at Emory Healthcare, details how cryoablation can be used by radiologists to manage pain in patients with cancer.
Results from the phase 3 ARCHES trial confirm the survival benefit of enzalutamide plus androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer.
The last century of development in radiation oncology has been about targeting.
According to new research, genetic determinants of PSA proved to robustly predict prostate cancer diagnoses and improve the detection of aggressive disease; however, larger and more diverse studies are still required.
A team of experts is recommending that doctors forgo describing early, low-grade prostate tumors as "cancers" as a way to ease anxiety among patients and their families and reduce unnecessary treatment.
Data presented at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium highlight the inhibitors’ use in combination regimens, other settings, and next-generation agents.
Patients with perineural invasion had a 4-fold higher risk of biochemical recurrence.
Neeraj Agarwal, MD, and Simon Chowdhury, MD, review final results from the TITAN study of apalutamide in patients with mCSPC and discuss the clinical implications of the findings.
At least 85 percent of all radical prostatectomies in the United States today are performed robotically.